Report cover image

Protein Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape

Publisher Prodture
Published Oct 31, 2024
Length 135 Pages
SKU # PROD19315174

Description

Protein Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape


The global protein therapeutics market is expected to grow at a CAGR of around 5.9% during 2025-2034. This report on global protein therapeutics market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global protein therapeutics market by segmenting the market based on product, application, end user, and region. Also, detailed profiles of companies operating in the protein therapeutics market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Rise in Prevalence of Chronic Diseases
• Increasing Geriatric Population
• Development of Plasma Derived Therapies
• Increasing Awareness for Protein-Based Therapeutics

Market Challenges

• High Development & Manufacturing Cost
• Stringent Government Regulations
• Complex Reimbursement Scenario

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Product

• Monoclonal Antibodies
• Insulin
• Fusion Protein
• Erythropoietin
• Interferon
• Human Growth Hormone
• Follicle Stimulating Hormone

Market by Application

• Metabolic Disorders
• Immunologic Disorders
• Hematological Disorders
• Cancer
• Hormonal Disorders
• Genetic Disorders
• Others

Market by End User

• Hospitals And Clinics
• Specialty Centers

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
Rest of Middle East & Africa

Table of Contents

135 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Protein Therapeutics Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Protein Therapeutics Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Protein Therapeutics Market by Product
5.1. Introduction
5.2. Monoclonal Antibodies
5.3. Insulin
5.4. Fusion Protein
5.5. Erythropoietin
5.6. Interferon
5.7. Human Growth Hormone
5.8. Follicle Stimulating Hormone
6. Global Protein Therapeutics Market by Application
6.1. Introduction
6.2. Metabolic Disorders
6.3. Immunologic Disorders
6.4. Hematological Disorders
6.5. Cancer
6.6. Hormonal Disorders
6.7. Genetic Disorders
6.8. Others
7. Global Protein Therapeutics Market by End User
7.1. Introduction
7.2. Hospitals And Clinics
7.3. Specialty Centers
8. Global Protein Therapeutics Market by Region
8.1. Introduction
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Netherlands
8.2.8. Rest of the Europe
8.3. North America
8.3.1. United States
8.3.2. Canada
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Indonesia
8.4.7. Rest of the Asia Pacific
8.5. Latin America
8.5.1. Mexico
8.5.2. Brazil
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. Turkey
8.6.3. Iran
8.6.4. United Arab Emirates
8.6.5. Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. Abbott Laboratories
12.2.2. Amgen, Inc.
12.2.3. AstraZeneca PLC
12.2.4. Baxter International, Inc.
12.2.5. Biogen, Inc.
12.2.6. Boehringer Ingelheim International GmbH
12.2.7. Chugai Pharmaceutical Co., Ltd.
12.2.8. Diasome Pharmaceuticals, Inc.
12.2.9. Eli Lilly and Company
12.2.10. F. Hoffmann-La Roche AG
12.2.11. Genentech, Inc.
12.2.12. Generex Biotechnology Corporation
12.2.13. GeneScience Pharmaceuticals Co., Ltd.
12.2.14. Hualan Biological Engineering, Inc.
12.2.15. Johnson & Johnson
12.2.16. Kyowa Hakko Kirin Co., Ltd.
12.2.17. Merck Serono SA
12.2.18. Novo Nordisk A/S
12.2.19. Oramed Pharmaceuticals Inc.
12.2.20. Sandoz International GmbH
12.2.21. Teva Pharmaceutical Industries Ltd.
List of Figures
Figure 1: Global Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 2: Global Protein Therapeutics Market by Product, 2024
Figure 3: Global Protein Therapeutics Market by Application, 2024
Figure 4: Global Protein Therapeutics Market by End User, 2024
Figure 5: Global Protein Therapeutics Market by Region, 2024
Figure 6: Global Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 7: Global Protein Therapeutics Market by Product (in %), 2024 & 2034
Figure 8: Global Monoclonal Antibodies Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 9: Global Monoclonal Antibodies Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 10: Global Insulin Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 11: Global Insulin Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 12: Global Fusion Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 13: Global Fusion Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 14: Global Erythropoietin Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 15: Global Erythropoietin Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 16: Global Interferon Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 17: Global Interferon Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 18: Global Human Growth Harmone Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 19: Global Human Growth Harmone Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 20: Global Follicle Stimulating Hormone Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 21: Global Follicle Stimulating Hormone Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 22: Global Protein Therapeutics Market by Application (in %), 2024 & 2034
Figure 23: Global Metabolic Disorders Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 24: Global Metabolic Disorders Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 25: Global Immunologic Disorders Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 26: Global Immunologic Disorders Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 27: Global Hematological Disorders Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 28: Global Hematological Disorders Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 29: Global Cancer Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 30: Global Cancer Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 31: Global Hormonal Disorders Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 32: Global Hormonal Disorders Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 33: Global Genetic Disorders Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 34: Global Genetic Disorders Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 35: Global Other Applications Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 36: Global Other Applications Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 37: Global Protein Therapeutics Market by End User (in %), 2024 & 2034
Figure 38: Global Hospitals and Clinic Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 39: Global Hospitals and Clinic Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 40: Global Specialty Centers Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 41: Global Specialty Centers Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 42: Global Protein Therapeutics Market by Region (in %), 2024 & 2034
Figure 43: Europe Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 44: Europe Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 45: Europe Protein Therapeutics Market by Country (in %), 2024 & 2034
Figure 46: Germany Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 47: United Kingdom Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 48: France Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 49: Italy Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 50: Spain Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 51: Russia Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 52: Netherlands Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 53: North America Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 54: North America Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 55: North America Protein Therapeutics Market by Country (in %), 2024 & 2034
Figure 56: United States Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 57: Canada Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 58: Asia Pacific Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 59: Asia Pacific Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 60: Asia Pacific Protein Therapeutics Market by Country (in %), 2024 & 2034
Figure 61: China Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 62: Japan Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 63: India Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 64: South Korea Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 65: Australia Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 66: Indonesia Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 67: Latin America Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 68: Latin America Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 69: Latin America Protein Therapeutics Market by Country (in %), 2024 & 2034
Figure 70: Mexico Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 71: Brazil Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 72: Argentina Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 73: Middle East & Africa Protein Therapeutics Market (in US$ Million), 2020-2024
Figure 74: Middle East & Africa Protein Therapeutics Market (in US$ Million), 2025-2034
Figure 75: Middle East & Africa Protein Therapeutics Market by Country (in %), 2024 & 2034
Figure 76: Saudi Arabia Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 77: Turkey Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 78: Iran Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 79: UAE Protein Therapeutics Market (in US$ Million), 2020-2034
Figure 80: Market Value Chain
List of Tables
Table 1: Global Protein Therapeutics Market Portraiture
Table 2: Global Protein Therapeutics Market by Product (in US$ Million), 2024 & 2034
Table 3: Global Protein Therapeutics Market by Application (in US$ Million), 2024 & 2034
Table 4: Global Protein Therapeutics Market by End User (in US$ Million), 2024 & 2034
Table 5: Global Protein Therapeutics Market by Region (in US$ Million), 2024 & 2034
Table 6: Europe Protein Therapeutics Market by Country (in US$ Million), 2024 & 2034
Table 7: North America Protein Therapeutics Market by Country (in US$ Million), 2024 & 2034
Table 8: Asia Pacific Protein Therapeutics Market by Country (in US$ Million), 2024 & 2034
Table 9: Latin America Protein Therapeutics Market by Country (in US$ Million), 2024 & 2034
Table 10: Middle East & Africa Protein Therapeutics Market by Country (in US$ Million), 2024 & 2034
Table 11: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us